SCI Pharmtech Inc (4119) — Capital Reinvestment Ratio
Latest as of March 2026:
2.91x
SCI Pharmtech Inc (4119) has a Capital Reinvestment Ratio of 2.91x as of March 2026, meaning it reinvests 3% of its operating cash flow (NT$36.89 Million) in capital expenditures (NT$107.34 Million). See 4119 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2.91x
Capex / Operating Cash Flow
Operating Cash Flow
NT$36.89 Million
TWD
Capital Expenditures
NT$107.34 Million
TWD
Data as of
Mar 2026
Most recent filing
SCI Pharmtech Inc Capital Reinvestment Ratio (2002–2025)
This chart tracks SCI Pharmtech Inc's Capital Reinvestment Ratio across 23 annual periods.
Annual Capital Reinvestment Ratio for SCI Pharmtech Inc (2002–2025)
Year-by-year Capital Reinvestment Ratio for SCI Pharmtech Inc from 2002 to 2025. For live market cap and broader valuation context, see market cap of SCI Pharmtech Inc.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.77x | NT$220.32 Million | NT$610.00 Million | ▲ +151.7% |
| 2024 | 1.10x | NT$860.52 Million | NT$946.64 Million | ▼ -76.9% |
| 2023 | 4.77x | NT$215.77 Million | NT$1.03 Billion | ▲ +21.2% |
| 2022 | 3.94x | NT$296.56 Million | NT$1.17 Billion | ▲ +42.4% |
| 2021 | 2.77x | NT$280.28 Million | NT$774.98 Million | ▲ +1133.9% |
| 2020 | 0.22x | NT$971.53 Million | NT$217.70 Million | ▼ -13.3% |
| 2019 | 0.26x | NT$791.60 Million | NT$204.49 Million | ▼ -23.6% |
| 2018 | 0.34x | NT$480.18 Million | NT$162.44 Million | ▼ -35.4% |
| 2017 | 0.52x | NT$281.65 Million | NT$147.39 Million | ▲ +48.3% |
| 2016 | 0.35x | NT$502.11 Million | NT$177.20 Million | ▲ +7.6% |
| 2015 | 0.33x | NT$663.24 Million | NT$217.51 Million | ▼ -68.1% |
| 2014 | 1.03x | NT$358.77 Million | NT$369.15 Million | ▼ -68.2% |
| 2013 | 3.24x | NT$238.57 Million | NT$773.01 Million | ▲ +590.6% |
| 2012 | 0.47x | NT$385.57 Million | NT$180.90 Million | ▼ -20.7% |
| 2011 | 0.59x | NT$249.55 Million | NT$147.71 Million | ▼ -31.9% |
| 2010 | 0.87x | NT$218.96 Million | NT$190.34 Million | ▲ +52.1% |
| 2009 | 0.57x | NT$316.96 Million | NT$181.13 Million | ▲ +1.5% |
| 2008 | 0.56x | NT$245.29 Million | NT$138.12 Million | ▼ -43.6% |
| 2007 | 1.00x | NT$167.53 Million | NT$167.21 Million | ▼ -18.9% |
| 2006 | 1.23x | NT$131.62 Million | NT$162.00 Million | ▲ +165.3% |
| 2004 | 0.46x | NT$76.61 Million | NT$35.55 Million | ▼ -4.3% |
| 2003 | 0.48x | NT$206.86 Million | NT$100.29 Million | ▲ +24.4% |
| 2002 | 0.39x | NT$107.12 Million | NT$41.73 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow